The Boston Globe

Stahl Criminal Defense Lawyers' Andrew Olesnycky Earns Best Lawyers® Listing for Criminal Defense: General Practice

Retrieved on: 
Thursday, September 29, 2022
Crime, ESPN, Press, Private attorney general, Arson, Illegal drug trade, The Star-Ledger, Lawyer, Privacy, News, Supreme Court of New Jersey, Supreme court, Criminal law, Lists of crime films, Sexual assault, The Boston Globe, Domestic violence, Union County, Associated Press, CBS, Heath Ledger, District, Family medicine, Steven Naifeh, Private investigator, The New York Times

And as Certified NJ Criminal Defense attorney, Olesnycky is among 1% of criminal defense lawyers who have been certified by the New Jersey Supreme Court.

Key Points: 
  • And as Certified NJ Criminal Defense attorney, Olesnycky is among 1% of criminal defense lawyers who have been certified by the New Jersey Supreme Court.
  • In addition to his criminal defense work, Mr. Olesnycky serves on the Criminal Justice Act Panel of Private Attorneys in the District of New Jersey.
  • Stahl Criminal Defense Lawyers have successfully defended hundreds of individuals targeted by investigations or formally accused of state and federal crimes.
  • Founded in 1997, the firm's criminal defense attorneys have more than 60 years of combined criminal law experience for both defense and prosecution.

Award-Winning Scholastic Kids Press Program Announces 2022-23 Kid Reporters

Retrieved on: 
Wednesday, September 28, 2022
Literacy, Winter Olympic Games, Student, Journalism, The Daily Show, Byline, Kid, News, NEW, Company, Climate change, Environment, Ruby Bridges, Government, Program, The Boston Globe, Nut, Sport, NASDAQ, Interview, Research, Parent, Multimedia, Education, View, Summer Olympic Games, Scholastic News Kids Press Corps, Outline, Toy, Scholastic

NEW YORK, Sept. 28, 2022 /PRNewswire/ -- As kids continue to navigate and make sense of complex global events as well as the goings-on in their community, staying informed and understanding the news is critical. To provide a platform for young people, Scholastic is announcing the 29 student journalists from around the world who will join the award-winning Scholastic Kids Press program for the 2022-2023 academic year. Thirteen new and 16 returning students ages 10-14 will interview newsmakers and cover events that matter most to their peers, writing "news for kids, by kids."

Key Points: 
  • To provide a platform for young people, Scholastic is announcing the 29 student journalists from around the world who will join the award-winning Scholastic Kids Press program for the 2022-2023 academic year.
  • Meet the 2022 2023 team of Scholastic Kid Reporters: http://www.scholastic.com/kidspress
    "Scholastic Kids Press has provided me with so many life-changing opportunities and experiences," said 13-year-old Scholastic Kid Reporter Zhoril Tapo.
  • Bylines will appear on the Scholastic Kids Press website and in select issues of Scholastic Magazines+, which reach more than 25 million students in U.S. classrooms.
  • "The enthusiasm and passion our Kid Reporters have for covering the news is inspiring," said Suzanne McCabe, editor of Scholastic Kids Press.

Boston Globe Media and Point32Health Collaborate on the Second Season of "Turning Points," a Podcast Series Helping People Navigate Mental Health

Retrieved on: 
Wednesday, September 28, 2022
Income, Health, Love, The Boston Globe, Harvard Pilgrim Health Care, LLC, BGMP, Population, Turning Point, Tufts Health Plan, News, Grief, Industry, Mental health, CEO, Quality of life, Solution, Podcasts (software), Boston.com, Studio B Productions, Boston Red Sox, Multimedia, STAT, View, Shelly Bell, Television, Music, Public relations, Stitcher Radio, Frantz (film), Spotify

BOSTON, Sept. 28, 2022 /PRNewswire/ -- Boston Globe Media and Point32Health , the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, have partnered again to launch season two of their podcast series called Turning Points , focusing on important conversations around mental health.

Key Points: 
  • BOSTON, Sept. 28, 2022 /PRNewswire/ -- Boston Globe Media and Point32Health , the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, have partnered again to launch season two of their podcast series called Turning Points , focusing on important conversations around mental health.
  • About Boston Globe Media Partners, LLC
    Boston Globe Media Partners, LLC provides news and information, entertainment, opinion and analysis through its multimedia properties.
  • Boston Globe Media offers leading integrated advertising solutions that connect communities, ideas, and causes through powerful storytelling and multimedia experiences.
  • Point32Health is a leading health and wellbeing organization, delivering an ever-better health care experience to everyone in our communities.

Sun Life named a Top Workplace by the Hartford Courant for third consecutive year

Retrieved on: 
Friday, September 23, 2022
Sun, Disability, Health, AAC, Culture, Child, TSX, AZ Business Magazine, NYSE, Sun Life Financial, Human, Hartford Courant, SLF, Life, Woman, Workplace, The Boston Globe, Bermuda, United Kingdom, National Partnership, DE, Family, Insurance, Society for Human Resource Management, New Mexico Bank & Trust Building, Richard Courant, Color, PSE, Management, Health insurance, Financial services, Bloomberg

Sun Life has also received the Top Workplaces U.S.A. recognition for two consecutive years, and has been named a Top Workplace by the Boston Globe for four consecutive years, making the top ten for the region's largest companies in 2020 and 2021.

Key Points: 
  • Sun Life has also received the Top Workplaces U.S.A. recognition for two consecutive years, and has been named a Top Workplace by the Boston Globe for four consecutive years, making the top ten for the region's largest companies in 2020 and 2021.
  • Sun Life also offers a sabbatical program that gives employees an opportunity to disconnect and spend time on personal and/or professional growth.
  • Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients.
  • ), except in New York, where policies are issued by Sun Life and Health Insurance Company (U.S.) (Lansing, Mich.).

Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics Conference

Retrieved on: 
Monday, September 19, 2022
Rubius, Investor, Twitter, Red Cell, Providence Business News, Nasdaq, U.S. Securities and Exchange Commission, News, LinkedIn, Company, Private Securities Litigation Reform Act, Therapy, The Boston Globe, Cancer, Degenerative disease, Conference, GLOBE, SEC, El Rubius, RED, Security (finance), Facebook

A live audio webcast will be available within the Investors & Media section of the Rubius Therapeutics website.

Key Points: 
  • A live audio webcast will be available within the Investors & Media section of the Rubius Therapeutics website.
  • An archived replay will be accessible for 90 days following the event.
  • Rubius Therapeutics is a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases.
  • We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made.

Reason vs. Racism: New Book Unveils Hidden History of Race Relations and the Newspaper Industry

Retrieved on: 
Friday, September 16, 2022
The Washington Post, OH, Pittsburgh, Journalism, Justice, Publication, Hope, The New York Times, The Boston Globe, Pittsburgh Post-Gazette, Environment, Block Communications, History, BCI, Racism, Vanity Fair, Family, Awareness, Ku Klux Klan, The Blade (Toledo, Ohio), Entertainment, Amazon

Award-winning author Jack Lessenberry's provocative book, Reason vs. Racism: A Newspaper Family, Race and Justice, provides an inside look at how one family approached racism in America through journalism.

Key Points: 
  • Award-winning author Jack Lessenberry's provocative book, Reason vs. Racism: A Newspaper Family, Race and Justice, provides an inside look at how one family approached racism in America through journalism.
  • Lessenberry has written for the New York Times, The Washington Post, The Boston Globe, and Vanity Fair.
  • Highlighted in the book are stories about undercover work to expose racism, and even a politician involved with the Klu Klux Klan.
  • Reason vs. Racism: A Newspaper Family, Race and Justiceis available on Amazon.

Independent Bank Corp. Announces Quarterly Dividend

Retrieved on: 
Thursday, September 15, 2022
Banking, Professional Services, Finance, Nasdaq, Inclusion, Culture, The Boston Globe, National Association of Affordable Housing Lenders, Community Reinvestment Act, Rockland Trust, Bank, Employee resource group, New England Regional Art Museum, Shotter v Westpac Banking Corp, Equal housing lender, Trust, Board, FDIC, Diversity, Community, Education, Board of directors

The Board of Directors of Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, today announced a $0.51 per share dividend.

Key Points: 
  • The Board of Directors of Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company, today announced a $0.51 per share dividend.
  • The dividend will be payable on October 7, 2022, to stockholders of record as of the close of business on September 26, 2022.
  • Independent Bank Corp. (NASDAQ Global Select Market: INDB) is the holding company for Rockland Trust Company, a full-service commercial bank headquartered in Massachusetts.
  • To find out why Rockland Trust is the bank "Where Each Relationship Matters," please visit RocklandTrust.com.

Rubius Therapeutics Announces Strategic Update

Retrieved on: 
Tuesday, September 13, 2022
Rubius, Investor, RCC, Solar cycle 12, Corporation, Anal cancer, Twitter, Autoimmunity, Red Cell, Sale, EDT, NSCLC, Providence Business News, Nivolumab, Nasdaq, U.S. Securities and Exchange Commission, News, Colorectal cancer, LinkedIn, Company, Carcinoma, Review, Private Securities Litigation Reform Act, Melanoma, Therapy, Red blood cell, The Boston Globe, Patient, Cancer, AES, Protein, Webcast, Cell, Head, Degenerative disease, Renal cell carcinoma, Research, Large-cell lung carcinoma, GLOBE, SEC, RED, El Rubius, Pembrolizumab, Spleen, HIV disease progression rates, Security (finance), Fine chemical, Pharmaceutical industry, Vaccine, Facebook

CAMBRIDGE, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced plans to restructure the Company and align resources to advance its next generation red blood cell-based cell conjugation platform.

Key Points: 
  • With more than 80 patients dosed across three clinical trials to date, Rubius Therapeutics has demonstrated that engineered red blood cells can be manufactured at scale, safely administered and activate a patients immune system, resulting in clinical benefit in certain cancer patients, including evidence of tumor shrinkage and prolonged stable disease in PD-(L)-1 refractory solid tumors, said Pablo J. Cagnoni, M.D., president and chief executive officer of Rubius Therapeutics.
  • Based on these early findings, we firmly believe in the potential of Red Cell Therapeutics for the treatment of cancer and autoimmunity.
  • An audio webcast will be available on the Events and Presentations page within the Investors and Media section of the Rubius Therapeutics website and can be directly accessed here .
  • Rubius Therapeutics is a biopharmaceutical company that is developing an entirely new class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases.

Rubius Therapeutics to Provide Strategic Update

Retrieved on: 
Monday, September 12, 2022
Rubius, Investor, Twitter, Red Cell, EDT, Providence Business News, News, LinkedIn, Company, Therapy, The Boston Globe, Cancer, Nasdaq, Degenerative disease, GLOBE, RED, El Rubius, Webcast, Pharmaceutical industry, Facebook

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases, today announced that the Company plans to provide a strategic update and host an investor teleconference and webcast on Tuesday, September 13, 2022, at 7:30 a.m. EDT.

Key Points: 
  • CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases, today announced that the Company plans to provide a strategic update and host an investor teleconference and webcast on Tuesday, September 13, 2022, at 7:30 a.m. EDT.
  • An audio webcast will be available on the Events and Presentations page within the Investors and Media section of the Rubius Therapeutics website and can be directly accessed here .
  • Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics.
  • Rubius initial focus is to advance RCT product candidates for the treatment of cancer and autoimmune diseases by leveraging two distinct therapeutic modalities potent cell-cell interaction and tolerance induction.

Benchmark Named to Best Workplaces in Aging Services List by FORTUNE Magazine, Recertified as a Great Place to Work®

Retrieved on: 
Monday, September 12, 2022
Culture, Great Places, Trust, 100 Best Workplaces in Europe, The Boston Globe, News, Life, Association of Jewish Aging Services, FORTUNE, CEO, Leadership, Fairness, Respect, Public relations, Healthcare, Medicine, Ageing

WALTHAM, Mass., Sept. 12, 2022   /PRNewswire-PRWeb/ -- Benchmark, the largest senior housing provider in New England, today announced that it was certified as a Great Place To Work for the fifth straight year and ranked 17th nationally as a Best Workplaces in Aging Services by FORTUNE magazine.

Key Points: 
  • "It's our dedicated and compassionate associates who make Benchmark such a special place to work a great place to work.
  • The Great Place to Work survey gauges employees' perceptions in five areas pride, respect, credibility, fairness and camaraderie with employee engagement and culture being critical criteria.
  • For the complete list of the 2022 Great Places to Work in Aging Services companies, visit https://www.greatplacetowork.com/best-workplaces/aging-services/2022 .
  • Benchmark has been named one of the Top Places to Work for 14 straight years in The Boston Globe's annual employee-based survey and received repeated recognition in FORTUNE's Best Workplaces for Aging Services list.